Home
IPS
Feedback
Subscribe
Top cited articles
Reader Login
Users Online : 3483
About
Editorial Board
Ahead of print
Current Issue
Archive
Search
Instructions
Announcement
Etcetera
Contact
Advertise
»
My Preferences
»
Manuscript submission
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
Access statistics : Table of Contents
2005| March-April | Volume 37 | Issue 2
Archives
Previous Issue
Next Issue
Most popular articles
Most cited articles
Hide all abstracts
Show selected abstracts
Export selected to
Viewed
PDF
Cited
EDUCATIONAL FORUM
Pleiotropic effects of statins
Vishal Tandon, G Bano, V Khajuria, A Parihar, S Gupta
March-April 2005, 37(2):77-85
DOI
:10.4103/0253-7613.15106
The lipid-lowering actions of statins are well known. However, recent studies provide compelling evidence that the clinical benefits of statin therapy may also be attributed to mechanisms independent of their cholesterol-lowering effects. These non-lipid-lowering (pleiotropic) effects of statin therapy are believed to include antiinflammatory actions, property to reverse endothelial dysfunction by decreasing LDL oxidation and increasing nitric oxide bioavailability. Their antioxidant actions, ability to provide plaque stability, favorable coagulation profile, ability to prevent platelet aggregation and normalize sympathetic outflow as well as their antiproliferative and immunosuppressive properties also contribute to the non-lipid-lowering effects. These pleiotropic effects shown by statin therapy offer many advantages over the currently available drugs for dyslipidemias. These additional benefits not only find therapeutic application in cardiovascular disorders but also in many other disease states.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
19,444
1,460
23
RESEARCH PAPER
Protective effect of
Aloe vera
L. gel against sulphur mustard-induced systemic toxicity and skin lesions
G Anshoo, S Singh, AS Kulkarni, SC Pant, R Vijayaraghavan
March-April 2005, 37(2):103-110
DOI
:10.4103/0253-7613.15110
OBJECTIVE: Sulphur mustard (SM), chemically 2,2'-dichloro diethyl sulphide, is an incapacitating and extremely toxic chemical warfare agent, and causes serious blisters on contact with human skin. SM forms sulphonium ion in the body that alkylates DNA and several other macromolecules, and induces oxidative stress. The aim of this study was to evaluate the protective effect of
Aloe vera
L. gel against SM-induced systemic toxicity and skin lesions. MATERIALS AND METHODS:
Aloe vera
gel was given (250, 500 and 1000 mg/kg) orally to mice as three doses, one immediately after SM administration by percutaneous route, and the other two doses on the next two days. Protective index was calculated with and without
Aloe vera
gel treatment. Aloe vera gel was also given orally as three doses with 3 LD50 SM and the animals were sacrificed for biochemical and histological evaluation, 7 days after SM administration. In another set of experiment
Aloe vera
gel was liberally applied on the SM administered skin site and the animals were sacrificed after 14 days to detect its protective effect on the skin lesions induced by SM. RESULTS: The protection given by
Aloe vera
gel was marginal. 1000 mg/kg dose of
Aloe vera
gel gave a protection index of 2.8. SM significantly decreased reduced glutathione (GSH), oxidised glutathione (GSSG) and WBC count, and significantly increased malondialdehyde (MDA) level, RBC count and Hb concentration.
Aloe vera
gel offered protection only in the increase of MDA level by SM. Severe damage was observed in the histology of liver, spleen and skin following SM administration, and 1000 mg/kg of
Aloe vera
gel partially protected the lesions. However, topical application of
Aloe vera
gel showed better protection of the skin lesions induced by SM. CONCLUSION: The study shows that percutaneous administration of SM induces oxidative stress and oral administration of
Aloe vera
gel could only partially protect it. Topical application of
Aloe vera
gel may be beneficial for protecting the skin lesions induced by SM.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
12,211
568
11
EDUCATIONAL FORUM
Recent trends in the nitrergic nervous system
P Roy, G Venkat Ramana, M UR Naidu, P Usha Rani
March-April 2005, 37(2):69-76
DOI
:10.4103/0253-7613.15105
The late 20th century witnessed the novel discovery of "Nitrergic" or "Nitroxidergic" innervation of the vascular smooth muscles, their role as a vasodilator in cerebral, ocular and penile vasculature, as well as their reciprocal action to adrenergic vasoconstriction. The identification of this nerve as a postganglionic parasympathetic nerve, the discovery of autonomic efferent nerves where Nitric oxide (NO) is the neurotransmitter (NTM) to blood vessels, its physiological role in the control of smooth muscle tone, and the pharmacological implications of NO have been reviewed. This will aid an in-depth analysis of vascular dysfunctions and the development of strategic pharmacotherapeutic interventions with time.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
10,701
509
3
Coxibs: The new super aspirins or unsafe pain killers?
SK Kulkarni, NK Jain
March-April 2005, 37(2):86-89
DOI
:10.4103/0253-7613.15107
The new generation of analgesics and antiinflammatory drugs, namely, the selective inhibitors of cyclooxygenase-2 (COX-2) enzymes, popularly known as Coxibs, have become a very popular class of drugs because of their gastro-sparing property. Coxibs were the widely prescribed drugs (nearly 8 million people round the globe take these drugs) until the recent setback with rofecoxib, which was withdrawn from the market by the innovator due to increased risk of heart attacks and strokes observed with its long-term use. The withdrawal of this popular NSAID has not only caused a great setback in the global market of coxibs but has also questioned the ethics involved in the toxicity testing and sharing of information with the end users of this new class of drugs. This article briefly reviews the developments in coxib theory, the clinical efficacy and safety of these agents in the light of the latest cardiovascular concerns.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
10,745
407
10
RESEARCH PAPER
Pharmacological investigations of
Sapindus trifoliatus
in various
in vitro
and
in vivo
models of inflammation
DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar, SK Arora
March-April 2005, 37(2):96-102
DOI
:10.4103/0253-7613.15109
OBJECTIVE: To investigate the effect of lyophilized aqueous extract of pericarps of
Sapindus trifoliatus
(ST) in various
in vitro
and
in vivo
inflammatory models. METHODS: ST was studied for its
in vitro
inhibitory activity against 5-lipoxygenase (5-LO), cyclo-oxygenase (COX), leukotriene B4 (LTB4) and nitric oxide synthase (NOS). At doses 20 and 100 mg/kg, i.p. ST was evaluated in acute pedal inflammation induced by carrageenan, histamine, serotonin and zymosan in rats and mice. Further, the effect of topical application of the extract (1 mg and 5 mg) on ear inflammation induced by various inflammatory agents like -
O
-tetradecanoyl-phorbol 13-acetate (TPA) or capsaicin or arachidonic oxazolone or dinitrofluorobenzene (DNFB) was also investigated. RESULTS:
In vitro
evaluation of the extract revealed its inhibitory activity against the major inflammatory mediators 5-LO, COX, LTB4 and NOS. The extract significantly inhibited the pedal inflammation produced by carrageenan, histamine, serotonin and zymosan. Further, topical application of ST significantly inhibited the ear inflammation induced by acute and multiple applications of TPA and acute application of capsaicin or arachidonic acid. However, the extract failed to inhibit ear inflammation induced by oxazolone or DNFB. CONCLUSION: ST has antiinflammatory activity possibly mediated through 5-LO and COX pathways.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
10,136
572
10
RESEARCH LETTER
Antidermatophytic activity of
Pistia stratiotes
VG Premkumar, D Shyamsundar
March-April 2005, 37(2):127-128
DOI
:10.4103/0253-7613.15116
[FULL TEXT]
[PDF]
[CITATIONS]
10,049
283
7
RESEARCH PAPER
Investigations of
Sapindus trifoliatus
in dopaminergic and serotonergic systems: Putative antimigraine mechanisms
DK Arulmozhi, A Veeranjaneyulu, SL Bodhankar, SK Arora
March-April 2005, 37(2):120-125
DOI
:10.4103/0253-7613.15114
OBJECTIVE: To evaluate the potential dopaminergic and serotonergic receptor-mediated modulatory effect of the aqueous extract of
Sapindus trifoliatus
[(ST), (family: Sapindaceae)], a traditional phytomedicine used in the treatment of hemicrania (migraine), using animal models and receptor assays. MATERIALS AND METHODS: ST (at 20 and 100 mg/kg, i.p. doses) was evaluated for its effect on apomorphine-induced climbing behavior, 5-hydroxytryptophan (
l
-5-HTP)-induced serotonin syndrome, and MK-801-induced hyperactivity in mice. The radioligand binding studies for various receptors and enzymes were carried out (outsourced) using standard procedures at 250 µg/ml concentration of ST. RESULTS: ST significantly inhibited the apomorphine-induced climbing behavior, the
l
-5-HTP-induced serotonin syndrome and MK-801-induced hyperactivity in mice. In the receptor radioligand binding studies, ST exhibited affinity towards dopamine D2, 5-HT2A receptors. CONCLUSION: The results of the behavioral studies in mice indicate that ST modulated D2 and 5-HT2A receptor-mediated paradigms. The radioligand binding studies supported these observations, suggesting the possible involvement of dopaminergic and serotonergic mechanisms in the antimigraine activity of ST.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
9,853
373
5
Relaxant effect of
Cuminum cyminum
on guinea pig tracheal chains and its possible mechanism(s)
MH Boskabady, S Kiani, H Azizi
March-April 2005, 37(2):111-115
DOI
:10.4103/0253-7613.15111
OBJECTIVE: To examine the relaxant effects of the macerated and aqueous extracts of
Cuminum cyminum
on the tracheal chains of guinea pig. MATERIALS AND METHODS: The relaxant effects of cumulative concentrations of macerated and aqueous extracts (0.25, 0.5, 0.75 and 1.0 g%) in comparison with saline and theophylline (0.25, 0.5, 0.75, and 1.0 mM) were examined on pre-contracted tracheal chains of guinea pigs under different conditions. RESULTS: In Group 1 experiments (contracted by KCl) only the last two concentrations of theophylline and the highest concentration of macerated extract showed significant relaxant effect compared to that of saline (P<0.001 and P<0.05 for theophylline and macerated extract respectively). The effects of the last two concentrations of theophylline in this group were significantly greater than those of the macerated and aqueous extracts (P<0.001). However, in Group 2 experiments (contracted by methacholine) both the extracts and theophylline showed concentration-dependent relaxant effect compared to that of saline (P<0.05 to P<0.001). The effects of the two last concentrations of both extracts were significantly lower than those of theophylline in Group 2 experiments (P<0.05 to P<0.001). In Group 3 (non-incubated, contracted by methacholine) the extracts of
Cuminum cyminum
did not show any relaxant effect of tracheal chains. The relaxant effects of macerated and aqueous extracts in Groups 1 and 3 were significantly lower than those of Group 2 (P<0.05 to P<0.001). However, the effects of different concentrations of theophylline obtained in Group 1 and 2 were not significantly different. There was a significant correlation between the effects and concentrations of theophylline in Groups 1 and 2, macerated extract in Groups 2 and 3 and aqueous extract in Group 1 (P<0.05 to P<0.001). CONCLUSION: These results show a potent relaxant effect of
Cuminum cyminum
on guinea pig tracheal chains which may be due to a stimulatory effect of the plant on β-adrenoceptors and/or an inhibitory effect on histamine H1 receptors.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
9,796
373
9
RESEARCH LETTER
A study of the antimicrobial activity of
Elephantopus scaber
K Avani, S Neeta
March-April 2005, 37(2):126-127
DOI
:10.4103/0253-7613.15115
[FULL TEXT]
[PDF]
[CITATIONS]
9,375
436
13
EDITORIAL
Identifying a research topic: The problem is the problem…
B Gitanjali
March-April 2005, 37(2):67-68
DOI
:10.4103/0253-7613.15104
[FULL TEXT]
[PDF]
[CITATIONS]
9,470
270
4
RESEARCH PAPER
Skeletal muscle relaxant effect of Chonemorpha macrophylla in experimental animals
Ranendra Kumar Roy, NM Ray, AK Das
March-April 2005, 37(2):116-119
DOI
:10.4103/0253-7613.15113
OBJECTIVE: To study the skeletal muscle relaxant property of
Chonemorpha macrophylla
(CM). MATERIALS AND METHOD: The skeletal muscle relaxant effect of the alcoholic extract of CM was studied on isolated frog rectus abdominis muscle, isolated rat phrenic nerve diaphragm muscle preparation and in intact young chicks. The parameter studied in the isolated muscle or isolated nerve muscle preparations was the extent of inhibition of acetylcholine or electrically-induced contraction of skeletal muscles. In intact chicks, the drug was administered i.v. in wing veins and the onset, duration and nature of paralysis were recorded. In all the experiments, the effect of the drug was compared with that of gallamine and succinylcholine. RESULTS: The alcoholic extract of CM reduced the acetylcholine-induced contraction of isolated frog rectus abdominis and electrically stimulated contractions of rat phrenic nerve diaphragm in a dose-dependent manner. In unanaesthetized chicks, it produced spastic type of paralysis with extension of the neck and limbs. The effects were similar to the effects of succinylcholine but different from those of gallamine. CONCLUSION: The alcoholic extract of CM possesses skeletal muscle relaxant property. It produces depolarizing type of muscle paralysis similar to that produced by succinylcholine.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
7,583
275
3
In vivo
chromosome damaging effects of an inosine monophosphate dehydrogenase inhibitor: Ribavirin in mice
KP Seetharama Rao, K Narayana
March-April 2005, 37(2):90-95
DOI
:10.4103/0253-7613.15108
OBJECTIVE: To investigate the
in vivo
mutagenic effects of ribavirin in mice. METHODS: Mice were injected (i.p.) 20, 100, or 200 mg/kg ribavirin (single exposure) for bone marrow micronucleus, peripheral blood micronucleus and bone marrow chromosome aberration tests. Five treatments of 200 mg/kg ribavirin was given (i.p.) for sperm morphology test. The tests were performed as per the standard procedures. RESULTS: Ribavirin induced significant number of micronucleated polychromatic erythrocytes (MNPCEs) at 24, 48 and 72 h following the exposure with more effects at 24 h (p<0.05-0.001). Micronucleated PCEs were more at 48 h in lower dose-levels and at 72 h in highest dose-level in the peripheral blood (p<0.05-0.001). Ribavirin induced structural chromosomal damage hence producing the fragments for the micronucleus formation. Ribavirin decreased the PCE%, P/N ratio and the mitotic index indicating that it prevents cell division in mouse bone marrow. Ribavirin also decreased the testis weight and induced the formation of abnormal sperms. CONCLUSION: Ribavirin is a potent mutagen and cytotoxic agent in mice
in vivo
. Further, it also induces point mutations in germ cells yielding abnormal sperms. The genotoxic effects of ribavirin are not exerted in a dose-dependent pattern in mouse.
[ABSTRACT]
[FULL TEXT]
[PDF]
[CITATIONS]
7,500
251
14
MOLECULES OF THE MILLENNIUM
Ximelagatran: An oral direct thrombin inhibitor
C Girish, M Jayanthi
March-April 2005, 37(2):132-133
DOI
:10.4103/0253-7613.15119
[FULL TEXT]
[PDF]
[CITATIONS]
5,214
231
1
CASE STUDY
5-Fluorouracil associated encephalopathy: Case report
BS Yadav, SC Sharma
March-April 2005, 37(2):130-131
DOI
:10.4103/0253-7613.15118
[FULL TEXT]
[PDF]
[CITATIONS]
4,902
189
4
MOLECULES OF THE MILLENNIUM
Ghrelin: A potential drug target for obesity
AK Madan
March-April 2005, 37(2):133-134
DOI
:10.4103/0253-7613.15120
[FULL TEXT]
[PDF]
4,634
276
-
CASE STUDY
Fetal alcohol exposure: A case report
DN Mendhekar, A Dogra, V Girotra
March-April 2005, 37(2):129-130
DOI
:10.4103/0253-7613.15117
[FULL TEXT]
[PDF]
4,514
167
-
WEB-WISE
National Prescribing Service
J Singh
March-April 2005, 37(2):135-136
DOI
:10.4103/0253-7613.15121
[FULL TEXT]
[PDF]
3,200
135
-
Site Map
|
Home
|
Contact Us
|
Feedback
|
Copyright and Disclaimer
|
Privacy Notice
Online since 20
th
July '04
Published by Wolters Kluwer -
Medknow